ERVEBO Now Registered in Four African Countries

Merckhas confirmed that ERVEBO has now been registered by National Health Authorities in the following countries in Africa – DRC, Burundi, Ghana, and Zambia. 

ERVEBO was granted a conditional marketing authorization by the European Commission on November 11, 2019 and approved by

...

Continue Reading

Ebola vaccine safety to be studied 5 years post vaccination

The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.

The study will assess several factors of these treaments

  • long-term
...

Continue Reading

Paratek Awarded BARDA Project BioShield Contract for NUZYRA

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, has announced that the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR),

...

Continue Reading

Emergex Vaccine Candidate for Francisella Tularensis

Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing set-point vaccines to prevent serious infectious diseases, has  announced the successful completion of the first step in the development of a candidate vaccine for the Gram-negative intracellular

...

Continue Reading

Another Monkeypox case in the UK

On Tuesday December 3rd a patient was admitted to a specialist unit at St Thomas' Hospital in central London after Public Health England confirmed a diagnosis of Monkeypox. 

It is believed the individual contracted the virus whilst visting Nigeria, which has seen at least four

...

Continue Reading

Pneumonic Plague Diagnosed in Beijing

Two people have been diagnosed with Pneumonic Plague in Beijing’s Chaoyang district, both are currently in an unamed hospital and receiving treament. 

Chaoyang Hospital, where the two patients were initially treated, has taken the measure of replacing all the chairs at its

...

Continue Reading

Merck's Ebola Vaccine Granted Conditional Approval in the EU

Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola

...

Continue Reading

FDA Clears First Rapid Diagnostic Test for Ebola

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
...

Continue Reading

Ebola Therapy mAb114 Receives $14 million in Funding

It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of

...

Continue Reading

FDA Approve Smallpox/Monkeypox Vaccine

The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.

Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic

...

Continue Reading

Bertin Announce 2 Newcomers for Biological Threat Sampling

Bertin’s teams are proud to announce the release of 2 new air sampling equipment for biological air monitoring or biological recognition missions:

– The Coriolis Compact: dry cyclonic collector intended for air monitoring in a biological threat context.

– The Coriolis Nano:

...

Continue Reading

Explosion at VECTOR Laboratory

Monday, September 16th, saw reports emerge of an explosion at the Russian State Research Center of Virology and Biotechnology, known as Vector.

Continue Reading

Ebola Bombali Detected in Guinea

Researchers from The University of California, Davis, have recenctly publsihed their findings regarding the discovery of the sitxth ebolavirus, Bombali, in Angolan free-tailed bats roosting inside people’s houses in Guéckedou and Kissidougou, Guinea. 

The team from UC

...

Continue Reading

Defence Minister calls Bioterrorism a Contagious Plague

Speaking at the Shanghai Cooperation Organisation's (SCO) First Military Medicine Conference this week, India's Defence Minister Rajnath Singh referred to bioterrorism as a 'contagious plague', and called upon the Armed Forces Medical Services (AFMS) of the SCO countries to

...

Continue Reading

Man Pleads Guilty to Ricin Plot

A man from Los Angeles pleaded guilty this week to Federal charges of attempting to obtain ricin for unlawful purposes, namely to poison his wife!

Over a two-month period late last year, Steve S. Kim attempted to obtain ricin from what he thought was an online seller, but in fact was an

...

Continue Reading

Tearaway Tularemia

UPDATE: Case numbers have now reached over 800. 

Sweden is continuing to see an increase in the number of people affected by Tularemia this year.

At present there have been around 700 cases reported, and we are only just entering September. This is a much higher number than

...

Continue Reading

HHS Funds an Additional Year of Ebola Vaccine Manufacturing

As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support

...

Continue Reading

CDC Shuts Down USAMRIID Lab

Following an inspection in June, the CDC has issued a cease-and-desist order to the Fort Detrick biodefense lab. All research at the lab, run by the Army Medical Research Institute of Infectious Diseases (USAMRIID), is now on hold until further notice. 

The cease-and-desist

...

Continue Reading

DARPA Awards Grant to ASU for Fight Against WMDs

Arizona State University has announced that it has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to build a field-deployable, point-of-care device that will determine in 30 minutes or less if a person has been exposed to weapons of mass destruction or

...

Continue Reading

Ebola Outbreak 2018 - Present Health Information Guide

In response to the WHO declaring the Ebola outbreak in the DRC a Public Health Emergency of International Concern (PHEIC), the U.S. National Library of Medicine has made available to all the Ebola Outbreak: 2018-Present Health Information Guide. 

The guide can be found ...

Continue Reading

Don’t Blow It! Phase 2 Launch Event.

DASA is inviting expressions of interest for a launch event on 1 October 2019 for our 'Don’t Blow It! Safely eliminating chemical and biological munitions on the battlefield' competition.

This ...

Continue Reading

USAID Pledges $98 Million in Support for Ebola Outbreak

On July 2nd the United States Agency for International Development (USAID) announced they would be giving $98 million to the Democratic Republic of Congo (DRC) to assist in the fight against the current Ebola outbreak. 

"With this funding, USAID is providing lifesaving assistance,

...

Continue Reading

FBI investigates as Ricin scare prompts evacuation

The FBI is investigating the circumstances around an evacuation at a University of Minnesota apartment building this week due to reports of Ricin.

It was reported by CBS Minnesota that a student who lived in the complex called 911 on Tuesday, May 7th, saying she had eaten Ricin,

...

Continue Reading

Our Current Sponsors